{
  "id": "enwiki-001357954390",
  "slug": "ns-11821",
  "title": "NS-11821",
  "qid": "",
  "lead": "NS-11821, or NS11821 is a GABA A receptor positive allosteric modulator and nonbenzodiazepine which was under development for the treatment of anxiety disorders and CNS disorders but was never marketed. It is taken orally. The drug is a subunit-selective partial positive allosteric modulator of the GABA A receptor. More specifically, it shows affinity (K i ) values of 1.6 nM at α 1 , 9.7 nM at α 2 , 3.8 nM at α 3 , and 2.5 nM at α 5 , whereas it shows ( ) values of (4%) at α 1 , 59 nM (17%) at α 2 , 73 nM (40%) at α 3 , and 44 nM (41%) at α 5 . Based on animal studies, this is expected to translate into a profile of anxiolytic effects with low propensity for sedation. Clinical findings of NS-11821 in humans have been described. NS-11821 was under development by NeuroSearch. It reached phase 1 clinical trials for both anxiety disorders and CNS disorders prior to the discontinuation of its development in 2017. The chemical structure of NS-11821 does not yet appear to have been disclosed.",
  "body": "NS-11821, or NS11821 is a GABA A receptor positive allosteric modulator and nonbenzodiazepine which was under development for the treatment of anxiety disorders and CNS disorders but was never marketed. It is taken orally. The drug is a subunit-selective partial positive allosteric modulator of the GABA A receptor. More specifically, it shows affinity (K i ) values of 1.6 nM at α 1 , 9.7 nM at α 2 , 3.8 nM at α 3 , and 2.5 nM at α 5 , whereas it shows ( ) values of (4%) at α 1 , 59 nM (17%) at α 2 , 73 nM (40%) at α 3 , and 44 nM (41%) at α 5 . Based on animal studies, this is expected to translate into a profile of anxiolytic effects with low propensity for sedation. Clinical findings of NS-11821 in humans have been described. NS-11821 was under development by NeuroSearch. It reached phase 1 clinical trials for both anxiety disorders and CNS disorders prior to the discontinuation of its development in 2017. The chemical structure of NS-11821 does not yet appear to have been disclosed.",
  "categories": [
    "102101369",
    "102102928",
    "106462793",
    "106462794",
    "23603337",
    "26220375",
    "26974467",
    "27236659",
    "28387434",
    "37750075",
    "43371250",
    "50769796",
    "54374437",
    "61955657",
    "63007578",
    "63999785",
    "68150358",
    "90826088"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1357954390",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1780675580.0,
  "claims": [],
  "contradictions": [],
  "confidence": 0.6,
  "csl": {
    "id": "enwiki-001357954390",
    "type": "webpage",
    "title": "NS-11821",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/ns-11821",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          21
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          21
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001357954390",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1357954390",
    "note": "Immutable snapshot enwiki-001357954390"
  }
}